F744-0209 Screening compound: N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-2,2-diphenylacetamide

F744-0209 Screening compound: N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-2,2-diphenylacetamide
F744-0209 Screening compound: N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F744-0209
N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F744-0209

Molecular Formula

C27H31N3O4S (C27 H31 N3 O4 S)

Compound Name

N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-2,2-diphenylacetamide

IUPAC name

N-{2-[4-(4-methoxybenzenesulfonyl)piperazin-1-yl]ethyl}-22-diphenylacetamide

SMILES

COc(cc1)ccc1S(N1CCN(CCNC(C(c2ccccc2)c2ccccc2)=O)CC1)(=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.554

Distribution Coefficient, logD

3.541

Water Solubility, LogSw

-3.77

Polar Surface Area

67.267

Acid Dissociation Constant (pKa)

12.50

Base Dissociation Constant (pKb)

5.90

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.60

F744-0209 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F744-0209 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F744-0209?
Check Price and Availability of F744-0209, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F744-0209 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F744-0209
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F744-0209
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F744-0209 available by request